News Digest / Ticker: GSK

Ticker: GSK

05:29am, Tuesday, Jun 09, 2026

GSK Shares Slip After $10.6 Billion Nuvalent Buyout

GSK's stock dipped over 2% following its $10.6 billion acquisition of US biotech firm Nuvalent, centered on promising lung cancer treatments with FDA breakthrough designations. The deal carries a notable premium and plans to fuel revenue by 2027.

03:27am, Tuesday, May 12, 2026

Hengrui Pharma's Stock Jumps on Massive $1B Collaboration with Bristol-Myers

07:52am, Wednesday, Feb 04, 2026

GSK's New CEO Signals Slower 2026 Sales Growth Amid Strategic Pipeline Build-Up

07:16am, Wednesday, Jan 28, 2026

London's FTSE 100 Slips Amid Healthcare and Banking Sell-Offs

08:48am, Monday, Jan 05, 2026

China Greenlights GSK's Nucala for Adult COPD Patients with Elevated Eosinophils

04:59am, Friday, Dec 12, 2025

GSK's Arexvy RSV Vaccine Recommended for All Adults by European Regulators

07:44am, Thursday, Nov 20, 2025

Moderna Secures $1.5B Loan, Aims for 10% Revenue Rise in 2026 Amid Pipeline Shifts

07:31am, Monday, Oct 06, 2025

GSK to File Leucovorin Autism Label After FDA's ~40‑Case Review - 4-6 Month Fast‑Track Could Lift Sales, Squeeze Hikma

03:49am, Wednesday, Sep 17, 2025

GSK $30B, Eli Lilly $5B: Pharma's $350B U.S. Onshore Rush as 250% Tariffs Loom

08:43am, Wednesday, Jul 16, 2025

GSK Shares Slip After FDA Flags Eye Safety Risks in Blood Cancer Drug Review

02:30am, Monday, Jul 14, 2025

GSK Targets Younger Adults with RSV Vaccine: What This Means for Stock Traders and Market Dynamics

07:22am, Monday, Jan 13, 2025

GSK's $1.15 Billion Bet on IDRx: A Strategic Pivot in Cancer Treatment that Traders Should Watch

04:10am, Thursday, Oct 10, 2024

GSK Stock Soars 6.6% Following $2.2 Billion Lawsuit Settlement, Paving the Way for Stability

04:55am, Wednesday, Jul 03, 2024

GSK Acquires CureVac's Vaccine Division, Pivots to mRNA Innovation Amid 24% Stock Surge

07:49am, Thursday, Jun 27, 2024

Tech Stocks Drag Market Down; Micron, Levi Strauss, Walgreens Lead Premarket Decline

04:37am, Thursday, Jun 27, 2024

GSK's Stock Plummets 6% After CDC Curbs RSV Vaccine Guidelines